Business Description
Tiziana Life Sciences Ltd
NAICS : 541714
SIC : 2834
ISIN : GB00BKWNZY55
Description
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.31 | |||||
| Equity-to-Asset | 0.17 | |||||
| Debt-to-Equity | 0.1 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 16.5 | |||||
| 3-Year EPS without NRI Growth Rate | 17 | |||||
| 3-Year FCF Growth Rate | -9.4 | |||||
| 3-Year Book Growth Rate | -55.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -37.79 | |||||
| 12-1 Month Momentum % | -68.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.85 | |||||
| Quick Ratio | 0.85 | |||||
| Cash Ratio | 0.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.4 | |||||
| Shareholder Yield % | 0.15 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -199.09 | |||||
| ROA % | -101.52 | |||||
| ROIC % | -254.12 | |||||
| ROC (Joel Greenblatt) % | -5104.72 | |||||
| ROCE % | -215.95 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 52.5 | |||||
| Price-to-Tangible-Book | 58.5 | |||||
| EV-to-EBIT | -6.42 | |||||
| EV-to-EBITDA | -6.47 | |||||
| EV-to-FCF | -24.79 | |||||
| Earnings Yield (Greenblatt) % | -15.58 | |||||
| FCF Yield % | -4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tiziana Life Sciences Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | |||
| EPS (TTM) (£) | 0 | ||
| Beta | 0 | ||
| Volatility % | 100.65 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (£) | 0.086386 | ||
| 20-Day SMA (£) | 0 | ||
| 12-1 Month Momentum % | -68.13 | ||
| 52-Week Range (£) | 0.6 - 3.9 | ||
| Shares Outstanding (Mil) | 97.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tiziana Life Sciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tiziana Life Sciences Ltd Stock Events
| Event | Date | Price(£) | ||
|---|---|---|---|---|
| No Event Data | ||||
Tiziana Life Sciences Ltd Frequently Asked Questions
What is Tiziana Life Sciences Ltd(LSE:TILS)'s stock price today?
The current price of LSE:TILS is £0.59. The 52 week high of LSE:TILS is £3.90 and 52 week low is £0.60.
When is next earnings date of Tiziana Life Sciences Ltd(LSE:TILS)?
The next earnings date of Tiziana Life Sciences Ltd(LSE:TILS) is 2024-12-27 Est..
Does Tiziana Life Sciences Ltd(LSE:TILS) pay dividends? If so, how much?
Tiziana Life Sciences Ltd(LSE:TILS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers